Treatment of acute promyelocytic leukemia during pregnancy

Pharmacotherapy

Volumn 29, Issue 6, 2009, Pages 709-724

  Yang, Daisy ^a   Hladnik, Lindsay ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b BARNES JEWISH HOSPITAL   (United States)

Author keywords

Acute promyelocytic leukemia; APL; Hematology; Pregnancy; Treatment

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTHRAQUINONE DERIVATIVE; ANTIMETABOLITE; ARSENIC TRIOXIDE; CORTICOSTEROID DERIVATIVE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; GEMTUZUMAB OZOGAMICIN; IDARUBICIN; MERCAPTOPURINE; METHOTREXATE; MITOGUAZONE; MITOXANTRONE; PREDNISONE; PURINE DERIVATIVE; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RETINOIC ACID; TIOGUANINE; VINCRISTINE;

ALOPECIA; ANTINEOPLASTIC ACTIVITY; BLOOD TRANSFUSION; BONE MARROW SUPPRESSION; BRAIN TOXICITY; CANCER REGRESSION; CANCER RELAPSE; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL TRIAL; CONJUNCTIVITIS; CONTINUOUS INFUSION; DIARRHEA; DISEASE ASSOCIATION; DISSEMINATED INTRAVASCULAR CLOTTING; DIZZINESS; DRUG DOSE REDUCTION; DRUG ERUPTION; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; FATIGUE; FETUS MALFORMATION; FIRST TRIMESTER PREGNANCY; FLUID RETENTION; HEADACHE; HEART ARRHYTHMIA; HUMAN; HYPOKALEMIA; INFUSION SITE REACTION; LIVER TOXICITY; MUCOSA INFLAMMATION; MUCOSAL DRYNESS; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUROPATHY; PREGNANCY; PROMYELOCYTIC LEUKEMIA; QT PROLONGATION; RETINOIC ACID SYNDROME; REVIEW; SECOND TRIMESTER PREGNANCY; SIDE EFFECT; SPONTANEOUS ABORTION; THIRD TRIMESTER PREGNANCY; THROMBOCYTE TRANSFUSION; TREATMENT DURATION; VISUAL DISORDER; VOMITING;

ABNORMALITIES, DRUG-INDUCED; ABORTION, THERAPEUTIC; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY COMPLICATIONS, NEOPLASTIC; PREGNANCY OUTCOME; TRETINOIN;

EID: 66749169699     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.29.6.709     Document Type: Review

References (71)

1. Kantarjian H, O'Brien S, Cortes J, et al. Therapeutic advances in leukemia and myelodysplastic syndrome over the past 40 years. Cancer 2008;113(7 suppl):1933-1952
2. Oduncu FS, Kimmig R, Hepp H, Emmerich B. Cancer in pregnancy: maternal-fetal conflict. J Cancer Res Clin Oncol 2003;129:133-146 (Pubitemid 36583694)
3. Chelghoum Y, Vey N, Raffoux E, et al. Acute leukemia during pregnancy: a report on 37 patients and a review of the literature. Cancer 2005;104:110-117 (Pubitemid 40847758)
4. Alegre A, Chunchurreta R, Rodriguez-Alarcon J, Cruz E, Prada M. Successful pregnancy in acute promyelocytic leukemia. Cancer 1982;49:152-153 (Pubitemid 12196150)
5. Sanz MA, Rafecas FJ. Successful pregnancy during chemotherapy for acute promyelocytic leukemia [case report]. N Engl J Med 1982;306:939.
6. Fassas A, Kartalis G, Klearchou N, Tsatalas K, Sinacos Z, Mantalenakis S. Chemotherapy for acute leukemia during pregnancy: five case reports. Nouv Rev Fr Hematol 1984;26:19-24. (Pubitemid 14135077)
7. Artlich A, Moller J, Tschakaloff A, Schwinger E, Kruse K, Gortner L. Teratogenic effects in a case of maternal treatment for acute myelocytic leukemia: neonatal and infantile course. Eur J Pediatr 1994;153:488-491 (Pubitemid 24210278)
8. Simone MD, Stasi R, Venditti A, et al. All-trans-retinoic acid (ATRA) administration during pregnancy in relapsed acute promyelocytic leukemia. Leukemia 1995;9:1412-1413
9. Lin C, Huang M, Liu H, Chang IY, Tsai CH. Successful treatment of acute promyelocytic leukemia in a pregnant Jehovah's witness with all-trans-retinoic acid, rhG-CSF, and erythropoietin. Am J Hematol 1996;51:251-252 (Pubitemid 26086378)
10. Ebert U, Loffler H, Kirch W. Cytotoxic therapy and pregnancy. Pharmacol Ther 1997;74:207-220 (Pubitemid 27340586)
11. Greenlund L, Letendre L, Teffei A. Acute leukemia during pregnancy: a single institutional experience with 17 cases. Leuk Lymphoma 2001;41:571-577 (Pubitemid 32717309)
12. Siu BL, Alonzo MR, Vargo TA, Fenrich AL. Transient dilated cardiomyopathy in a newborn exposed to idarubicin and all-trans-retinoic acid (ATRA) early in the second trimester of pregnancy. Int J Gynecol Cancer 2002;12:399-402. (Pubitemid 34839840)
13. Catanzarite VA, Ferguson JE. Acute leukemia and pregnancy: a review of management and outcome. Obstet Gynecol Surv 1984;39:663-678 (Pubitemid 15223041)
14. Bartsch HH, Meyer D, Teichmann AT, Speer CP. Treatment of promyelocytic leukemia during pregnancy: a case report and review of the literature. Blut 1988;57:51-54 (Pubitemid 18193236)
15. D'Emilio A, Dragone P, De Negri G, Montaldi A, Stella M, Battista R. Acute myelogenous leukemia in pregnancy. Haematologica 1989;74:601-604 (Pubitemid 20095914)
16. Harrison P, Chipping P, Fothergill GA. Successful use of all-trans- retinoic acid in acute promyelocytic leukemia presenting during the second trimester of pregnancy. Br J Haematol 1994;86:681-682 (Pubitemid 24199068)
17. Stentoft J, Nielsen JL, Hvidman LE. All-trans-retinoic acid in acute promyelocytic leukemia in late pregnancy. Leukemia 1994;8:S77-80.
18. Watanabe R, Okamoto S, Moriki T, Kizaki M, Kawai Y, Ikeda Y. Treatment of acute promyelocytic leukemia with all-trans-retinoic acid during the third trimester of pregnancy. Am J Hematol 1995;48:210-211
19. Requena A, Velasco JG, Pinilla J, Gonzalez-Gonzalez A. Acute leukemia during pregnancy: obstetric management and perinatal outcome of two cases. Eur J Obstet Gynecol Reprod Biol 1995;63:139-141 (Pubitemid 26008825)
20. Incerpi MH, Miller DA, Posen R, Byrne JD. All-trans-retinoic acid for the treatment of acute promyelocytic leukemia in pregnancy. Obstet Gynecol 1997;89:826-828
21. Garcia L, Valcarcel M, Santiago-Borrero PJ. Chemotherapy during pregnancy and its effects on the fetus: neonatal myelosuppression - two case reports. J Perinatol 1999;19:230-233
22. Delgado-Lamas JL, Garces-Ruiz OM. Malignancy: case report: acute promyelocytic leukemia in late pregnancy - successful treatment with all-trans-retinoic acid (ATRA) and chemotherapy. Hematology 2000;4:415-418
23. Giagounidis AAN, Beckmann MW, Giagounidis AS, et al. Acute promyelocytic leukemia and pregnancy. Eur J Haematol 2000;64:267-271 (Pubitemid 30186785)
24. Fadilah SA, Hatta AZ, Keng CS, Jamil MA, Singh S. Successful treatment of acute promyelocytic leukemia in pregnancy with all-trans-retinoic acid. Leukemia 2001;15:1665-1666
25. Breccia M, Cimino G, Alimena G, De Carolis S, Lo Coco F, Mandelli F. AIDA treatment for high-risk acute promyelocytic leukemia in a pregnant woman at 21 weeks of gestation [case report]. Haematologica 2002;87(2):ELT12.
26. Carradice D, Austin N, Bayston K, Ganly PS. Successful treatment of acute promyelocytic leukemia during pregnancy. Clin Lab Haem 2002;24:307-311 (Pubitemid 35216316)
27. Ali R, Ozkalemkas F, Ozcelik T, et al. Maternal and fetal outcomes in pregnancy complicated with acute leukemia: a single institutional experience with 10 pregnancies at 16 years. Leuk Research 2003;27:381-385 (Pubitemid 36287198)
28. Dilek I, Topcu N, Demir C, et al. Hematological malignancy and pregnancy: a single-institution experience of 21 cases. Clin Lab Haem 2006;28:170-176 (Pubitemid 43752215)
29. Valappil S, Kurkar M, Howell R. Outcome of pregnancy in women treated with all-trans-retinoic acid: a case report and review of literature. Hematology 2007;12:415-418
30. Wallace PJ. Complete remission in acute promyelocytic leukemia despite the persistence of the 15;17 translocation. Am J Hematol 1989;31:266-268 (Pubitemid 19188524)
31. Hoffman MA, Wiernik PH, Kleiner GJ. Acute promyelocytic leukemia and pregnancy. Cancer 1995;76:2237-2241
32. Nakamura K, Dan K, Iwakiri R, Gomi S, Nomura T. Successful treatment of acute promyelocytic leukemia in pregnancy with all-trans retinoic acid. Ann Hematol 1995;71:263-264 (Pubitemid 26020534)
33. Lipovsky MM, Biesma DH, Christiaens G, Petersen EJ. Successful treatment of acute promyelocytic leukemia with all-trans-retinoic acid during late pregnancy. Br J Haematol 1996;94:699-701. (Pubitemid 26308904)
34. Sham RL. All-trans-retinoic acid-induced labor in a pregnant patient with acute promyelocytic leukemia [case report]. Am J Hematol 1996;53:145. (Pubitemid 26377707)
35. Terada Y, Shindo T, Endoh A, Watanabe M, Fukaya T, Yajima A. Fetal arrhythmia during treatment of pregnancy-associated acute promyelocytic leukemia with all-trans-retinoic acid and favorable outcome. Leukemia 1997;11:292-296
36. Consoli U, Figuera A, Milone G, et al. Acute promyelocytic leukemia during pregnancy: report of 3 cases. Int J Hematol 2004;79:31-36 (Pubitemid 38182198)
37. Takitani K, Hino N, Terada Y, et al. Plasma all-trans-retinoic acid level in neonates of mothers with acute promyelocytic leukemia. Acta Haematol 2005;114:167-169
38. Jabbour EJ, Estey E, Kantarjian H. Adult acute myeloid leukemia. Mayo Clin Proc 2006;81:247-260 (Pubitemid 43205780)
39. Sanz MA, Tallman MS, Lo Coco F. Tricks of the trade for the appropriate management of newly diagnosed acute promyelocytic leukemia. Blood 2005;105:3019-3025 (Pubitemid 40504316)
40. Sanz MA, Martin G, Rayon C, et al. A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RAR-positive acute promyelocytic leukemia. Blood 1999;94:3015-3021 (Pubitemid 29512705)
41. Estey E, Garcia-Manero G, Ferrajoli A, et al. Use of all-trans-retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia. Blood 2006;107;3469-3473
42. Ades L, Chevret S, Raffoux E, et al. Is cytarabine useful in the treatment of acute promyelocytic leukemia? Results of a randomized trial from the European acute promyelocytic leukemia group. J Clin Oncol 2006;24:5703-5710 (Pubitemid 46631312)
43. Sanz MA, Martin G, Gonzalez M, et al. Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group. Blood 2004;103:1237-1243
44. National Comprehensive Cancer Network, Inc. Acute myeloid leukemia NCCN clinical practice guidelines in oncology (version 1.2008), 2006. Available from http://www.nccn.org. Accessed May 1, 2008.
45. Lo Coco F, Cimino G, Breccia M, et al. Gemtuzumab ozogamicin (Mylotarg) as a single agent for molecularly relapsed acute promyelocytic leukemia. Blood 2004;104:1995-1999. (Pubitemid 39297848)
46. Mandelli F, Diverio D, Avvisati G, et al. Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans-retinoic acid and idarubicin (AIDA) therapy. Blood 1997;90;1014-1021
47. Fenaux P, Chastang C, Chevret S, et al. A randomized comparison of all-trans-retinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. Blood 1999;94:1192-1200
48. Shen ZX, Chen GQ, Ni JH, et al. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL). II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood 1997;89:3354-3360
49. Soignet SL, Maslak P, Wang ZG, et al. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med 1998;339:1341-1348 (Pubitemid 28509343)
50. Roche Laboratories, Inc. Vesanoid (tretinoin) package insert. Nutley, NJ; 2004.
51. Douer D, Tallman M. Arsenic trioxide: new clinical experience with an old medication in hematologic malignancies. J Clin Oncol 2005;23:2396-2410 (Pubitemid 46218734)
52. Rahman A, Vahter M, Ekstrom E, et al. Association of arsenic exposure during pregnancy with fetal loss and infant death: a cohort study in Bangladesh. Am J Epidemiol 2007;165:1389-1396 (Pubitemid 47234306)
53. Huyck KL, Kile ML, Mahiuddin G, et al. Maternal arsenic exposure associated with low birth weight in Bangladesh. J Occup Environ Med 2007;49:1097-1104 (Pubitemid 350287342)
54. Micromedex Healthcare Series [intranet database], version 5.1. Greenwood Village, CO: Thomson Healthcare.
55. Germann N, Goffinet F, Goldwasser F. Anthracyclines during pregnancy: embryo-fetal outcome in 160 patients. Ann Oncol 2004;15:146-150 (Pubitemid 38139617)
56. Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol 2004;5:283-291 (Pubitemid 38541580)
57. Pai VB, Nahata MC. Cardiotoxicity of chemotherapeutic agents: incidence, treatment, and prevention. Drug Saf 2000;22:263-302. (Pubitemid 30213944)
58. Chugun A, Uchide T, Tsurimaki C, et al. Mechanisms responsible for reduced cardiotoxicity of mitoxantrone compared to doxorubicin examined in isolated guinea-pig heart preparations. J Vet Med Sci 2008;70:255-264
59. Feldkamp M, Carey JC. Clinical teratology counseling and consultation case report: low dose methotrexate exposure in the early weeks of pregnancy. Teratology 1993;47:533-539 (Pubitemid 23172495)
60. Doll DC, Ringenberg S, Yarbro JW. Antineoplastic agents and pregnancy. Semin Oncol 1989;16:337-346 (Pubitemid 19259007)
61. Williams SF, Schilsky RL. Antineoplastic drugs administered during pregnancy. Semin Oncol 2000;27:618-622
62. Wagner VM, Hill JS, Weaver D, Baehner RL. Congenital abnormalities in baby born to cytarabine treated mother. Lancet 1980;2:98-99
63. Murrin RJA, Adjetey V, Harrison P, Warwick A. Acute promyelocytic leukaemia presenting as postpartum haemorrhage. Clin Lab Haem 2004;26:233-237 (Pubitemid 38736869)
64. Sharma JB, Gupta N, Vimala N, Anand M, Deka D, Mittal S. Acute promyelocytic leukemia: an unusual cause of fatal secondary postpartum hemorrhage. Arch Gynecol Obstet 2006;273:310-311 (Pubitemid 43221251)
65. Morimatsu Y, Matsubara S, Hirose N, et al. Acute promyelocytic leukemia: an unusual cause showing prolonged disseminated intravascular coagulation after placental abruption. Arch Gynecol Obstet 2008;277:267-270
66. Katagiri S, Tsubakio T, Minami G, et al. Successful embolization for uterine hemorrhage in a patient with acute promyelocytic leukemia. Acta Haematol 1983;70:119-121
67. Patatanian E, Thompson DF. Retinoic acid syndrome: a review. J Clin Pharm Ther 2008;33:331-338
68. Ment LR, Oh W, Ehrenkranz RA, Philip AG, Duncan CC, Makuch RW. Antenatal steroids, delivery mode, and intraventricular hemorrhage in preterm infants. Am J Obstet Gynecol 1995;172:795-800.
69. Crowley PA. Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972 to 1994. Am J Obstet Gynecol 1995;173:322-335
70. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972;50:515-525
71. Doubilet PM, Benson CB, Nadel AS, Ringer SA. Improved birth weight table for neonates developed from gestations dated by early ultrasonography. J Ultrasound Med 1997;16:241-249 (Pubitemid 27391822)